Straits Logo 1-01 (1).png
Radiation Oncology Market Size to Hit USD 28.07 Billion by 2033 | Straits Research New York, United States , Nov. 11, 2024 (GLOBE NEWSWIRE) -- Radiation oncology (radiotherapy/radiotherapy) is a medical specialty that must be incorporated into interdisciplinary cancer treatment...
ITM_Logo_Claim_RGB_high-res.png
ITM to Participate in Upcoming Investor Conferences
11 nov. 2024 05h00 HE | ITM Isotope Technologies Munich SE
Garching / Munich, November 11, 2024 – ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech company, today announced its participation in two upcoming industry investor...
Unterzeichnung der Vereinbarung zwischen ITM, TUM, MRI
ITM, TUM und das TUM Universitätsklinikum unterzeichnen eine neue Rahmenvereinbarung zur Entwicklung innovativer radiopharmazeutischer Krebstherapien
24 oct. 2024 05h00 HE | ITM Isotope Technologies Munich SE
Neufahrn / Garching / München, 24. Oktober 2024 – ITM Isotope Technologies Munich SE (ITM), ein führendes radiopharmazeutisches Unternehmen, die Technische Universität München (TUM) und das TUM...
To formalize and sign the agreement, Udo J. Vetter, ITM Supervisory Board Chairman, Oliver Buck, ITM co-founder and Supervisory Board member, Dr. Mark
ITM, TUM, and TUM University Hospital Sign New Framework Agreement to Advance Innovative Radiopharmaceutical Cancer Treatments
24 oct. 2024 05h00 HE | ITM Isotope Technologies Munich SE
Neufahrn / Garching / Munich, Germany, October 24, 2024 – ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech company, the Technical University of Munich (TUM) and the TUM...
ITM_Logo_Claim_RGB_high-res.png
ITM and NTP Strengthen Global Radioisotope Production Capacities by Renewing their Technology License Agreement and Signing a Manufacturing and Supply Agreement for n.c.a. Lutetium-177
18 oct. 2024 05h00 HE | ITM Isotope Technologies Munich SE
  Extension of 2012 agreement grants NTP the rights to manufacture and distribute non-carrier-added Lutetium-177 (n.c.a. 177Lu)Companies enter into an additional manufacturing and supply...
22157.jpg
Radiotherapy Market Analysis and Forecast 2018-2030: China and India Witnessing Substantial Market Growth Due to Their Large Population Base and Efforts to Improve Cancer Treatment Facilities
03 oct. 2024 04h20 HE | Research and Markets
Dublin, Oct. 03, 2024 (GLOBE NEWSWIRE) -- The Radiotherapy Market (By Technology, Procedure, Application, End User, Country Analysis), Company Profiles, Market Dynamics, Trends & Recent...
GMILogo_Vertical-Gradient.png
Radiopharmaceuticals Market to hit USD 15.4 billion by 2032, says Global Market Insights Inc.
01 oct. 2024 04h30 HE | Global Market Insights Inc.
Selbyville, Delaware, Oct. 01, 2024 (GLOBE NEWSWIRE) -- Radiopharmaceuticals Market size was valued at USD 6.7 billion in 2023 and is expected to grow at a CAGR of 9.8% over the forecast...
ITM_Logo_Claim_RGB_high-res.png
ITM to Present at Upcoming Radiopharmaceutical Investor Conferences in New York City
19 sept. 2024 05h22 HE | ITM Isotope Technologies Munich SE
Garching / Munich, September 19, 2024 – ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech company, today announced its participation in two upcoming industry...
ITM_Logo_Claim_RGB_high-res.png
ITM Obtains Exclusive Worldwide License from Debiopharm for CA IX-Targeted Peptide-based Radiopharmaceutical Programs Targeting Solid Tumors
12 sept. 2024 05h00 HE | ITM Isotope Technologies Munich SE
ITM gains exclusive global development and commercialization rights to Debiopharm’s first-in-class, peptide-based theranostic pair which combines therapeutic compound, Debio 0228 ([177Lu]Lu-DPI-4452)...
SNS-INSIDER-300X300.jpg
Radiotherapy Market Size to Hit USD 11.18 Billion by 2032, Driven by Rising Global Cancer Rates and Advancements in Treatment Technology | SNS Insider
06 sept. 2024 08h36 HE | SNS Insider pvt ltd
Pune, Sept. 06, 2024 (GLOBE NEWSWIRE) -- Radiotherapy Market Size & Growth Analysis “According to SNS Insider, The Radiotherapy Market Size was valued at USD 7.01 Billion in 2023 and is...